# Trial for MicroPort's Firesorb BVS: FUTURE-III

> **NCT03660202** · NA · UNKNOWN · sponsor: **Shanghai MicroPort Medical (Group) Co., Ltd.** · enrollment: 1200 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Firesorb

## Key facts

- **NCT ID:** NCT03660202
- **Lead sponsor:** Shanghai MicroPort Medical (Group) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01
- **Primary completion:** 2020-06
- **Final completion:** 2024-06
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660202, "Trial for MicroPort's Firesorb BVS: FUTURE-III". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03660202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*